Market cap data unavailable. We couldn't positively verify this ticker's market cap is under $500M. Verify independently before trading.
Oncotelic Therapeutics, Inc.
- Market Cap
- Unavailable
- Price
- $0.0385
- % Change (Daily % change from the live per-ticker quote feed.)
- -0.09%
- Volume
- 7.3K
About
Oncotelic Therapeutics, Inc., an Agoura Hills, California-based clinical-stage biopharmaceutical company, specializes in developing therapeutics for rare oncological conditions. Its flagship therapeutic candidate, OT-101 – an antisense compound designed to inhibit TGF-ß2 – is currently undergoing Phase 3 clinical trials for both pancreatic cancer and glioblastoma. Beyond oncology, OT-101 is also being explored for its potential in treating various viral diseases, including severe acute respiratory syndrome (SARS) and coronaviruses. The company's pipeline further includes OXi4503, which is being advanced for acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS), and CA4P, intended for the treatment of advanced metastatic melanoma.
Quick stats
Shares outstanding—
Computed float224.0M
Float / sharesUnknown
Key info
SectorHealthcare
IndustryBiotechnology
CIK (Central Index Key — the unique ID the SEC assigns to every filer. Use it to look up the company's filings on EDGAR.)0000908259
Websitehttps://www.oncotelic.com
AI Summary
AI-generated1/39
minorneutraloperations update
OTCQB Virtual Investor Conference Presentations Now Available for On-Demand Viewing
Liberty Star Uranium & Metals Corp. participated in the OTCQB Virtual Investor Conference held on August 5 and 6.
The company's presentation is now available for on-demand viewing for the next 90 days.
Management is accepting requests for one-on-one meetings with investors through September 1.